S. 839 (112th): Combating Designer Drugs Act of 2011

Introduced:

Apr 14, 2011
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on July 28, 2011, in a previous session of Congress, but was not enacted.

Sponsor:

Amy Klobuchar

Senator from Minnesota

Democrat

Text:

Read Text »
Last Updated: Jul 28, 2011
Length: 4 pages

About the bill

Full Title

A bill to ban the sale of certain synthetic drugs.

The bill’s title was written by its sponsor.

Read CRS Summary >

History

Apr 14, 2011
 
Introduced

This is the first step in the legislative process.

Jul 28, 2011
 
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Details

Cosponsors
5 cosponsors (3D, 2R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no roll call votes related to this bill.

Subject Areas
Find Similar Bills

Search for similar bills.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: